Stockscreener 앱 받기
0.3281
3.02%
-0.0102
시간 외 거래:
.32
-0.0081
-2.47%
전일 마감가:
$0.3383
열려 있는:
$0.345
하루 거래량:
1.14M
Relative Volume:
0.12
시가총액:
$11.84M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.94%
1개월 성능:
+23.81%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.3149
$0.3495
1주일 범위
$0.3149
$0.39
52주 변동 폭
$0.265
$2.22
Profusa Inc Stock (PFSA) Company Profile
명칭
Profusa Inc
전화
212-494-9022
주소
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
PFSA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.3281 | 13.82M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Profusa Inc 주식(PFSA)의 최신 뉴스
Profusa files prospectus relates to resale of up to 42.6 mln shares - MarketScreener
Profusa injects additional USD 1M into digital treasury assets - Medical Buyer
Profusa Invests $1 Million in Digital Treasury Assets - TipRanks
Profusa makes second $1 million bitcoin investment to hedge risks By Investing.com - Investing.com Nigeria
Profusa invests additional $1 million in digital treasury assets - MSN
Profusa, Inc. announced that it has received $1 million in funding - MarketScreener
Profusa invests additional $1 million in bitcoin treasury assets By Investing.com - Investing.com South Africa
Profusa, Inc. Announces $1 Million Investment in Digital Treasury Assets to Support Biochemical Monitoring Technology - Quiver Quantitative
Second $1M Investment: Profusa Expands Bitcoin Digital Treasury Strategy; Ascent Funds $2M Tranche - Stock Titan
French vascular surgeon adopts Profusa’s oxygen monitoring tech By Investing.com - Investing.com Nigeria
French vascular surgeon adopts Profusa’s oxygen monitoring tech - Investing.com India
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base - The Manila Times
8% of French CLTI Cases: Profusa's Lumee Technology Gains Major Adoption from Leading Surgeon Network - Stock Titan
Profusa’s Risky Vision for High-Tech Medical Sensors - Finimize
Profusa Restructures Securities Agreement for Flexibility - MSN
Profusa Faces Nasdaq Listing Compliance Challenges - MSN
Profusa receives Nasdaq notices for minimum value and bid price compliance - Investing.com
Profusa Approves $100 Million Equity Line of Credit - MSN
This Penny Stock Is Surging on an Nvidia Boost. Should You Buy Shares Now or Stay Far Away? - Barchart.com
Profusa (PFSA) Stock: Soars 76% on NVIDIA-Powered AI Breakthrough in Biochemistry Monitoring - parameter.io
Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform - Yahoo Finance
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring - GlobeNewswire
Profusa, Inc. Adopts NVIDIA -Powered Technology to Build Ai-Driven Insight Portal for Continuous Biomarker Monitoring - MarketScreener
Profusa shareholders approve $100 million equity line of credit with Ascent Partners By Investing.com - Investing.com South Africa
Profusa shareholders approve $100 million equity line of credit with Ascent Partners - Investing.com Australia
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base - GlobeNewswire
300+ CLTI Patients Annually: Profusa's Oxygen Monitoring Tech Enters Major Belgian Hospital - Stock Titan
Profusa's Strategic Position in Digital Health Innovation - AInvest
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Digital Health Pioneer Profusa to Showcase Continuous Biochemistry Monitoring Tech at Major Conference - Stock Titan
Profusa announces commercial and clinical collaboration with head of angiography, Medical University of Graz, Austria - MarketScreener
Profusa Announces Commercial and Clinical Collaboration - GlobeNewswire
Leading Vascular Center Adopts Profusa's Real-Time Oxygen Monitoring Tech for 1,500 Annual Procedures - Stock Titan
Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria - The Manila Times
Profusa amends purchase agreement and note terms for convertible debt tranches - Investing.com Australia
Profusa Restructures Securities Agreement for Enhanced Flexibility - AInvest
Profusa Inc (PFSA) 재무 분석
Profusa Inc (PFSA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.83%
자본화:
|
볼륨(24시간):